Sentinel Analytic Packages
  1. Sentinel Analytic Packages

Sentinel Analytic Packages

Public
  1. Sentinel Analytic Packages
  2. Sentinel Analytic Packages

Commits

AuthorCommitMessageCommit dateIssues
Josie AndersonJosie Anderson
1ca366b5729Added Outcome Monitoring Following Semaglutide Use: A Self-Controlled Risk Interval Signal Identification Analysis
Viola SpahiuViola Spahiu
6b777c52cafreadme.md edited online with Bitbucket
Josie AndersonJosie Anderson
8addd82b127Updated cder_mpl2r_wp019
Emma WhitedEmma Whited
165f200a063readme.md edited online with Bitbucketadded cder_mpl2p_wp055
Viola SpahiuViola Spahiu
514d12da74freadme.md edited online with BitbucketAdded cder_mpl1r_wp259
Whitney ChlonWhitney Chlon
7f739a1d336added cder_mpl1p_wp092
Whitney ChlonWhitney Chlon
8e63bfb6a4dreadme.md edited online with Bitbucket
Whitney ChlonWhitney Chlon
4d53dec0149Added cder_mpl1p_wp090
Whitney ChlonWhitney Chlon
26dc95c016eAdded cder_mpl1p_wp092
Emma WhitedEmma Whited
74d8c986745Updated to add cder_sir_wp011
Josie AndersonJosie Anderson
361efb7d13bUpdated Rates of Diabetic Ketoacidosis (DKA) by Chronic Kidney Disease (CKD) Stage Among Patients with Type 1 Diabetes Mellitus (T1DM): A Propensity Score Matched Analysis
Josie AndersonJosie Anderson
276ff63722fAdded Incidence of Inflammatory Bowel Disease Following Dipeptidyl Peptidase-4 (DPP-4) Inhibitor Use in Patients with Type 2 Diabetes Mellitus: An Inverse Probability of Treatment Weighting AnalysisDPP-4
Lizzie BeersLizzie Beers
47b00f37f42Added cder_mpl2p_wp060
Aaron MadowAaron Madow
c1c35f3ff24Added cder_sir_wp010
Emma WhitedEmma Whited
488090ab776Added cder_sir_wp007 and cder_sir_wp008
Aaron MadowAaron Madow
ac2414b7662Added cder_sir_wp009
Lizzie BeersLizzie Beers
59dc8084b12added cder_mpl2p_wp039, cder_mpl2p_wp044, and cder_mpl2p_wp047
Emma WhitedEmma Whited
f0de93eb50bAdded Trends in Healthcare Utilization During the COVID-19 Pandemic: A Propensity Score Matched and Stratified Analysis and Trends in Healthcare Utilization During the COVID-19 Pandemic: A Follow Up Propensity Score Matched and Stratified AnalysisCOVID-19
Lizzie BeersLizzie Beers
e398c3af94aadded Characteristics and Drug Utilization in Pregnant Patients With COVID-19: A Propensity Score Matched AnalysisCOVID-19
Lizzie BeersLizzie Beers
c18f58bfb4bAdded Risk of Adverse Maternal Health Outcomes Among Pregnant Patients With and Without COVID-19: A Propensity Score Matched AnalysisCOVID-19
Lizzie BeersLizzie Beers
cd76ab78330added Risk of Adverse Neonatal Health Outcomes Among Pregnant Patients With and Without COVID-19: A Propensity Score Matched AnalysisCOVID-19
Whitney ChlonWhitney Chlon
73405bbfda1Added Intentional Self-Harm Following Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RA) Use in Patients with Diabetes: An Inverse Probability of Treatment Weighting Analysis and Intentional Self-Harm Following Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RA) Use in Patients with Obesity: A Descriptive AnalysisGLP-1
Emma WhitedEmma Whited
ef4bb477d97Added Serious Infection Following Ustekinumab Use in Patients with Crohn’s Disease: An Inverse Probability of Treatment Weighting Analysis
Lizzie BeersLizzie Beers
55057bbd3c0Added Interstitial Lung Disease (ILD) Rates in Patients with Inflammatory Bowel Disease (IBD) and Following IBD Advanced Therapy: A Descriptive Analysis
Lizzie BeersLizzie Beers
74bd440a81fAdded Interstitial Lung Disease (ILD) in Patients with Inflammatory Bowel Disease (IBD) and Following Vedolizumab or Natalizumab Initiation: A Descriptive Analysis
Emma WhitedEmma Whited
13545dab23bAdded Hydrochlorothiazide Use Following Labeling Update to Include the Risk of Non-Melanoma Skin Cancer: An Interrupted Time Series Analysis
Emma WhitedEmma Whited
51e68e63dd8Added Hydrochlorothiazide Use Following Labeling Update to Include the Risk of Non-Melanoma Skin Cancer: An Interrupted Time Series Analysis
Lizzie BeersLizzie Beers
1765e67a95dAdded Intentional Self-Harm Following Montelukast Use in Patients with Asthma: An Updated Analysis Using ICD-10-CM CodingICD-10
Lizzie BeersLizzie Beers
5a24c312d0dAdded Outcome Monitoring Following Dupilumab Use: A Signal Identification Analysis
Lizzie BeersLizzie Beers
804cab111ceAdded Outcome Monitoring Following Baloxavir Use: A Signal Identification Analysis
Emma WhitedEmma Whited
7746ff956baupdated cder_mpl2p_wp023 title
Emma WhitedEmma Whited
ed6dec4e481added cder_mpl2p_wp043
Emma WhitedEmma Whited
8307da78fdcadded cder_mpl2r_wp018
Lizzie BeersLizzie Beers
5ae7df5bf64added cder_sir_wp004
Whitney ChlonWhitney Chlon
dc2fde8b66dAdded Angioedema following Sacubitril/Valsartan Use in Patients with Heart Failure: An Updated Propensity Score Analysis
Lizzie BeersLizzie Beers
61a200827cfAdded cder_mpl2r_wp019
Whitney ChlonWhitney Chlon
dc100c0a709readme.md edited online with Bitbucket
Whitney ChlonWhitney Chlon
8b5979d5b90readme.md edited online with Bitbucket
Whitney ChlonWhitney Chlon
0300eeb0a1aAdded Race and Ethnicity Associations Among Patients Hospitalized with COVID-19: A Covariate Stratified AnalysisCOVID-19
Emma WhitedEmma Whited
a6cfabd103areadme.md edited online with Bitbucket
Lizzie BeersLizzie Beers
05128291a77added cder_mpl1p_wp072 and cder_mpl1p_wp063
Lizzie BeersLizzie Beers
016bb41f4efadded cder_mpl1r_wp228 and cder_mpl1r_wp240
Ryan SchoepleinRyan Schoeplein
2741f44dc58Removed duplicate "cder_mpl2r_wp012" entry to Table of Contents
Ryan SchoepleinRyan Schoeplein
e560969bf40Outcome Monitoring Following Zarxio Use: A Signal Identification Analysis
Ryan SchoepleinRyan Schoeplein
443efd98363Added Outcome Monitoring Following Ozempic Use in Patients with Type 2 Diabetes: A Signal Identification Analysis
Lizzie BeersLizzie Beers
9a8a8204821corrected a typo in the title of cder_mpl2p_wp011
Lizzie BeersLizzie Beers
e03bbf3d036moved cder_mpl2p_wp011 to the top of the table of contents
Lizzie BeersLizzie Beers
129ddf27207Added cder_mpl2p_wp024
Lizzie BeersLizzie Beers
be16cef05f3Added Seizures following Gadolinium-Based Contrast Agents Exposure: A Self-Controlled Risk Interval Analysis
Ryan SchoepleinJ SteinmanRyan Schoeplein
d939d9519a2Added Characterizing Pregnant Women With and Without Evidence of Heart Failure and Non-Pregnant Women With Heart Failure: A Propensity Score Matched Analysis